BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7535899)

  • 41. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
    Guan H; Cachofeiro V; Pucci ML; Kaminski PM; Wolin MS; Nasjletti A
    Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
    Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes.
    Komers R; Allen TJ; Cooper ME
    Diabetes; 1994 Oct; 43(10):1190-7. PubMed ID: 7926287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
    Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
    Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Attenuation by creatine of myocardial metabolic stress in Brattleboro rats caused by chronic inhibition of nitric oxide synthase.
    Constantin-Teodosiu D; Greenhaff PL; Gardiner SM; Randall MD; March JE; Bennett T
    Br J Pharmacol; 1995 Dec; 116(8):3288-92. PubMed ID: 8719809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Sodium intake and angiotensin in hypertension induced by chronic NO synthase inhibition in the rat].
    Jover B; Nafrialdi ; Herizi A; Mimran A
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1197-9. PubMed ID: 7510468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart.
    Pabla R; Curtis MJ
    Circ Res; 1995 Nov; 77(5):984-92. PubMed ID: 7554153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats.
    Navarro J; Sanchez A; Sáiz J; Ruilope LM; García-Estań J; Romero JC; Moncada S; Lahera V
    Am J Physiol; 1994 Dec; 267(6 Pt 2):R1516-21. PubMed ID: 7529003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
    Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
    Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
    Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats.
    Moreau C; Larivière R; Kingma I; Grose JH; Lebel M
    Clin Exp Hypertens; 2000; 22(7-8):663-74. PubMed ID: 11131043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse cardiac effects of exogenous angiotensin 1-7 in rats with subtotal nephrectomy are prevented by ACE inhibition.
    Burrell LM; Gayed D; Griggs K; Patel SK; Velkoska E
    PLoS One; 2017; 12(2):e0171975. PubMed ID: 28192475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats.
    Matsubara BB; Matsubara LS; Zornoff LA; Franco M; Janicki JS
    Basic Res Cardiol; 1998 Jun; 93(3):173-81. PubMed ID: 9689443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Vasodilator effect of nitric oxide is a necessary counter-regulation in the spontaneously hypertensive rat].
    Arnal JF; Battle T; Ménard J; Michel JB
    Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1193-6. PubMed ID: 7510467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat.
    Deng LY; Thibault G; Schiffrin EL
    Clin Exp Hypertens; 1993 May; 15(3):527-37. PubMed ID: 7683950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase.
    Li JS; Schiffrin EL
    Am J Hypertens; 1994 Nov; 7(11):996-1004. PubMed ID: 7531459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
    Bernátová I; Pechánová O; Simko F
    Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H; Ono Y; Frohlich ED
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.